Genmab — December 2015
-
Hvis jeg var short, så ville jeg godt nok være nervøs at sidde over ASH.
-
Min kommentar på Børsen Play i dag: http://play.borsen.dk/social/56605fda725ed7540a0c8e4c
-
NBI +2,37%.
-
Washington Post - For multiple myeloma community, a November to remember - https://www.washingtonpost.com/news/to-your-health/wp/2015/12/02/for-multiple-myeloma-community-a-november-to-remember/
-
Mens vi venter på julenissen. Her er lidt overraskende info: Lundbeckfonden er investor i River Vision som udvikler Genmab stoffet Teprotumumab. Jeg husker ikke tidslinien men mon ikke det skete samtidig med Unibody aftalen. Her er link: http://www.lundbeckfondventures.com/portfolio
-
Program for ASH. Tak til Dohk. http://www.proinvestor.com/debat/73786
-
Symposium om fremtidige behandlingsmuligheder i MM fra igår. Om nye mAb's ca 2:11:30 og fremad. For/imod brug af de nye mAb's i tidlig behandling (off-label) http://myeloma.org/ArticlePage.action?tabId=22&menuId=164&articleId=4710&aTab=-1&gParentType=menuite
-
Tak Mads Skjern. Især for dit starttidspunkt på videoen. De første to timer er en sej omgang at komme igennem.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind